Congresses

Discover the pioneering technologies and innovations that power our vision for the future of eye care. Dive into abstracts of the upcoming ophthalmologic congresses, highlighting the groundbreaking advancements and solutions that shape the landscape of ophthalmology, all integral to RetInSight’s commitment to empowering eye care professionals to preserve their patients’ vision throughout their lifetime.

DOG Deutsche Ophthalmologische Gesellschaft | 28.-30. September 2023 | Berlin

Abstracts & Talks

Klicken Sie auf die Titel, um zu den einzelnen Abstracts zu gelangen

Donnerstag, 28. September, 10:15 – 10:24 Uhr, Raum: Auditorium von Graefe

Leingang, Oliver: Do07-01 | Entwicklung und Validierung von OCT-basierten Algorithmen zur präzisen Quantifizierung von geographischer Atrophie im Behandlungsverlauf

Donnerstag, 28. September, 10:24 – 10:33 Uhr, Raum: Auditorium von Graefe

Reiter, Gregor: Do07-02 | AI-basierte Flüssigkeitsüberwachung bei neovaskulärer AMD in der realen Welt – Ergebnisse aus dem Fight Retinal Blindness! Register

Donnerstag, 28. September, 10:33 – 10:42 Uhr, Raum: Auditorium von Graefe

Kellner, Ulrich: Do07-03 | Verlaufskontrolle mit automatisierten Messungen von retinalen Flüssigkeitsvolumina und Volumenänderungen in der OCT bei Patienten mit neovaskulärer altersabhängiger Makuladegeneration

Donnerstag, 28. September, 10:42 – 10:51 Uhr, Raum: Auditorium von Graefe

Frank, Sophie: Do07-04 | Ergebnisse durch ultra-hochauflösende optische Kohärenztomographie bei der Quantifizierung retinaler Schichten mithilfe von künstlicher Intelligenz

Donnerstag, 28. September, 11:09 – 11:18 Uhr, Raum: Auditorium von Graefe

Kostolna, Klaudia: Do07-07 | Struktur-Funktion-Analyse bei intermediärer AMD: Einfluss des Volumens von retikulären Pseudodrusen und der Deep-learning-basierten Photorezeptor-Integrität auf die Netzhautfunktion

Freitag, 29. September, 10:42 – 10:51 Uhr, Raum: Auditorium von Graefe

Schmidt-Erfurth, Ursula: Fr08-04 | Komplementinhibitoren-Therapie bei geographischer Atrophie (GA): Funktionelle und morphologische Wirksamkeit und klinisch relevante Biomarker

Samstag, 30. September, 10:42 – 10:51 Uhr, Raum: Auditorium von Graefe

Mai, Julia: Sa08-04 | Focal Events bei intermediärer AMD als erstes Zeichen der Konversion in eine äußere Netzhautatrophie in der prospektiven PINNACLE Studie

Publikationen

Klicken Sie auf die Titel, um zu den einzelnen Publikationen zu gelangen

Riedl, Schmidt-Erfurth: Whitepaper, 2023
OCT-based applications of artificial intelligence in the management of neovascular and atrophic age-related macular degeneration

Riedl et al: Ophthalmology Retina, 2022
The Effect of Pegcetacoplan Treatment on Photoreceptor Maintenance in Geographic Atrophy Monitored by Artificial Intelligence-Based OCT Analysis

Schmidt-Erfurth et al: Ophthalmology, 2020
Application of Automated Quantification of Fluid Volumes to Anti-VEGF Therapy of Neovascular Age-Related Macular Degeneration

Schmidt-Erfurth et al: Progress in Retinal and Eye Research, 2022
AI-based monitoring of retinal fluid in disease activity and under therapy

Vogl et al: Ophthalmology Retina, 2023
Predicting Topographic Disease Progression and Treatment Response of Pegcetacoplan in Geographic Atrophy Quantified by Deep Learning

Mai et al: Ophthalmology, 2022
Comparison of Fundus Autofluorescence Versus Optical Coherence Tomography-based Evaluation of the Therapeutic Response to Pegcetacoplan in Geographic Atrophy.

Riedl et al: Ophthalmology Retina, 2022
The Effect of Pegcetacoplan Treatment on Photoreceptor Maintenance in Geographic Atrophy Monitored by Artificial Intelligence-Based OCT Analysis.

Vogl et al: Ophthalmology Retina, 2022
Predicting Topographic Disease Progression and Treatment Response of Pegcetacoplan in Geographic Atrophy Quantified by Deep Learning.

EURETINA European Society of Retina Specialists | 05.-08. October 2023 | Amsterdam

Abstracts & Talks

Click on the titles to view the content

Thursday, 05. October 15:13 – 15:19 CEST
Room: Emerald Room I Part of session: Free Paper Session 3: AMD I
Schmidt-Erfurth: Pegcetacoplan therapy in geographic atrophy (GA): Therapeutic effects on retinal pigment epithelium (RPE) and photoreceptor (PR) integrity and function in the phase III clinical trials

Friday, 06. October 8:32 – 8:40 CEST
Room: Grand Auditorium I Part of session: Euretina Session 4: Research Session
Schmidt-Erfurth: Artificial Intelligence-Based Analysis of Pegcetacoplan Treatment in Geographic Atrophy

Friday, 06. October 9:01 – 9:07 CEST
Room: E102 I Part of session: Free Paper Session 4: Imaging I
Mai: Importance of automated OCT analysis for the longitudinal monitoring of geographic atrophy in clinical trials and the real-world.

Friday, 06. October 11:01 – 11:07 CEST
Room: E102 | Part of session: Free Paper Session 5: Diabetes & Vascular Diseases I
Gerendas: Protocol T: DME retreatment based on CST and BCVA stability – Can we do better considering intraretinal fluid volumes as disease stability criterion?

Friday, 06. October 14:51 – 14:56 CEST
Room: Speakers Corner I Part of session: Speakers’ Corner 7: AMD II
Frank: High Resolution assessment of Retinal Pigment Epithelium and Photoreceptor integrity/disease in the progression of early to late non-exudative age-related macular degeneration.

Friday, 06. October 14:56 – 15:01 CEST
Room: Speakers Corner I Part of session: Speakers’ Corner 7: AMD II
Mares: AI-based retinal fluid monitoring correlated with automated photoreceptor thickness quantification in neovascular AMD in the Fight Retinal Blindness! registry.

Saturday, 07. October 13:31 – 13:36 CEST
Room: Speakers Corner I Part of session: Speakers’ Corner 11: Imaging
Kostolna: Quantification of disease activity in neovascular age-related macular degeneration throughout the most commonly used optical coherence tomography devices.

Recorded Talks

Papers & Publications